346 filings
8-K
AVDL
Avadel Pharmaceuticals plc
15 Apr 24
Regulation FD Disclosure
7:01am
8-K
AVDL
Avadel Pharmaceuticals plc
4 Mar 24
Other Events
3:51pm
8-K
AVDL
Avadel Pharmaceuticals plc
4 Mar 24
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial
6:35am
8-K
AVDL
Avadel Pharmaceuticals plc
8 Jan 24
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
7:20am
8-K
AVDL
Avadel Pharmaceuticals plc
8 Nov 23
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7:09am
8-K
c97dn
9 Aug 23
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
7:37am
8-K
41xi8z bwow
3 Aug 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:15pm
8-K
e8qffk1f u3
3 Aug 23
Departure of Directors or Certain Officers
7:30am
8-K
dmvv 3uvicriwq23m
5 Jun 23
Regulation FD Disclosure
7:05am
8-K
wg8 cnahfggy7gr05x
31 May 23
Other Events
4:15pm
8-K
gi0 gp231ht
4 May 23
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial
4:08pm
8-K
85oxnhqdoilaa
1 May 23
Regulation FD Disclosure
3:16pm
8-K
8udxtb
5 Apr 23
Entry into a Material Definitive Agreement
7:31am
8-K
201f1 hsit
3 Apr 23
Other Events
5:28pm
8-K
xku765 5awr01z
30 Mar 23
Entry into a Material Definitive Agreement
5:11pm
8-K
5ztskvf0gie7vo7e
30 Mar 23
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial
7:06am
8-K/A
wd1uhl
30 Mar 23
Entry into a Material Definitive Agreement
6:03am
8-K
uzlkywpk
29 Mar 23
Entry into a Material Definitive Agreement
12:00am
8-K
5hmrlhhvuk7h1p5e
22 Mar 23
Avadel Pharmaceuticals Announces FDA Authorization to Import Tentatively-Approved LUMRYZ™ Ahead of Anticipated Final Approval Decision
7:16am
8-K
c4o7tmttygcaw5 ontv
2 Mar 23
Other Events
7:16am